TheraRadar

Pharma Intelligence, Simplified

← Back
Data updated: Mar 10, 2026

HERITAGE PHARMA

CardiovascularNeurologyOphthalmology
Generics

HERITAGE PHARMA is a generic drug manufacturer focused on Cardiovascular, Neurology, Ophthalmology. Key products include LABETALOL HYDROCHLORIDE.

1972
Since
38
Drugs
-
Trials
502
Approved (2yr)

Key Drugs

No active drugs

Recent Activity

BUPROPION HYDROCHLORIDE 2026-02-25
Labeling
DOXYCYCLINE HYCLATE 2026-02-19
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
DOXYCYCLINE HYCLATE 2026-02-06
Labeling
BUMETANIDE 2026-02-05
CETIRIZINE HYDROCHLORIDE ALLERGY 2026-01-30
Labeling
DOXYCYCLINE HYCLATE 2026-01-26
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
DOXYCYCLINE HYCLATE 2026-01-20
Labeling
DOXYCYCLINE HYCLATE 2026-01-18
Labeling
SEC Filings Pro
Loading...

Therapeutic Focus

Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5

Cardiovascular 62%
8 drugs
Neurology 15%
2 drugs
Ophthalmology 8%
1 drugs
Dermatology 8%
1 drugs
Immunology 8%
1 drugs

Pipeline Strength Pro

Loading...

Competitors Pro

BAUSCH specialty
Dermatology, Immunology, Ophthalmology, Cardiovascular
Novartis big-pharma
Cardiovascular, Immunology, Ophthalmology
BAUSCH AND LOMB specialty
Ophthalmology, Cardiovascular, Dermatology, Immunology
Baxter specialty
Cardiovascular, Dermatology, Ophthalmology
AbbVie big-pharma
Immunology, Neurology, Ophthalmology